Johnson Investment Counsel’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,469
| Closed | -$354K | – | 717 |
|
|
2023
Q2 | $354K | Hold |
3,469
| – | – | ﹤0.01% | 538 |
|
|
2023
Q1 | $315K | Buy |
+3,469
| New | +$315K | ﹤0.01% | 540 |
|
|
2021
Q4 | – | Sell |
-3,469
| Closed | -$349K | – | 687 |
|
|
2021
Q3 | $349K | Hold |
3,469
| – | – | ﹤0.01% | 515 |
|
|
2021
Q2 | $491K | Sell |
3,469
-400
| -10% | -$56.6K | 0.01% | 443 |
|
|
2021
Q1 | $386K | Hold |
3,869
| – | – | 0.01% | 468 |
|
|
2020
Q4 | $478K | Hold |
3,869
| – | – | 0.01% | 407 |
|
|
2020
Q3 | $377K | Hold |
3,869
| – | – | 0.01% | 426 |
|
|
2020
Q2 | $604K | Hold |
3,869
| – | – | 0.01% | 362 |
|
|
2020
Q1 | $558K | Hold |
3,869
| – | – | 0.01% | 344 |
|
|
2019
Q4 | $791K | Hold |
3,869
| – | – | 0.01% | 354 |
|
|
2019
Q3 | $311K | Buy |
3,869
+400
| +12% | +$32.2K | 0.01% | 493 |
|
|
2019
Q2 | $327K | Hold |
3,469
| – | – | 0.01% | 491 |
|
|
2019
Q1 | $296K | Buy |
+3,469
| New | +$296K | 0.01% | 504 |
|
|
2018
Q4 | – | Sell |
-3,469
| Closed | -$283K | – | 658 |
|
|
2018
Q3 | $283K | Buy |
+3,469
| New | +$283K | 0.01% | 533 |
|